Clinical Trials Directory

Trials / Completed

CompletedNCT01094015

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice: a Prospective Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Consorci Sanitari de Terrassa · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysteroscopy diagnostic practice.

Conditions

Interventions

TypeNameDescription
DRUGlidocaine-prilocaine creamImplementation of 3 cm of lidocaine-prilocaine in the endocervical canal, 10 minutes before the intervention with a syringe without needle 5ml. Application, with a swab of the anesthetic cream ectocervix level.
OTHERgel application for the transmission of ultrasound3 cm of gel application for the transmission of ultrasound into the endocervical canal 10 minutes before surgery, with a 5ml syringe without needle. Application, with a swab in gel ectocervix

Timeline

Start date
2007-07-01
Primary completion
2009-01-01
Completion
2009-04-01
First posted
2010-03-26
Last updated
2010-04-09

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01094015. Inclusion in this directory is not an endorsement.

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice (NCT01094015) · Clinical Trials Directory